102.36000 EUR
0.94
0.93%
Last update Dec 17, 9:11 AM CET
Main market
Day range
101.20000
102.36000
Previous close
101.42000
Open
101.54000
Access this stock data via API
Subscribe
Gilead Sciences, Inc.
102.36
0.94
0.93%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 24.5B 27.1B 27.3B 27.3B
Cost of revenue 5.3B 6.5B 5.7B 6.6B
Gross profit 19.2B 20.6B 21.6B 20.7B
Operating expense
Research & development 5.0B 5.7B 5.0B 4.6B
Selling general and admin 5.2B 6.1B 5.7B 5.2B
Other operating expenses
Operating income 9.0B 8.8B 11.0B 10.9B
Non operating interest income
Income 239.5M
Expense 832.9M 944M 935M 1.0B
Other income expense -7.8B -1.0B -4.2B -1.6B
Pretax income 588.2M 6.9B 5.8B 8.3B
Tax provision 179.9M 1.2B 1.2B 2.1B
Net income 409.2M 5.6B 4.6B 6.2B
Basic EPS 0.4 4.5 3.7 5.0
Diluted EPS 0.4 4.5 3.6 4.9
Basic average shares 1.1B 1.3B 1.3B 1.3B
Diluted average shares 1.1B 1.3B 1.3B 1.3B
EBITDA 11.6B 11.7B 12.5B 12.3B
Net income from continuing op. 409.2M 5.6B 4.6B 6.2B
Minority interests 0 52M 26M 24M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 20 minutes

12:09
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).